Semaglutide Medications Ozempic and Wegovy Show No Higher Suicidal Ideation Risk in Extensive US Health Record Review
Compared to other medications for similar conditions, the use of semaglutide medications—Ozempic for type 2 diabetes and Wegovy for weight loss—is not linked to an increased risk of suicidal ideation, according to a comprehensive review of U.S. health records funded by the National Institutes of Health. Consoling Outcomes Despite Regulatory Review This analysis dispels worries … Read more